Novo's weight-loss drug Wegovy cuts risk of heart disease by 20
Novo Nordisk briefly overtakes LVMH as Europe's most valuable
EMEA Morning Briefing: Stock Futures Fall Ahead of PMI Data
Novo Nordisk nears LVMH as Europe's biggest firm by market value
Weight-loss aiding drugs like Novo Nordisk's Ozempic have promise
Novo Nordisk surpasses LVMH and becomes Europe's most valuable
LVMH aims to restore Tiffany's sparkle with $16.2 billion takeover
Novo Nordisk (NOVOB) Briefly Overtakes LVMH (MC) as Biggest
Drugmaker Novo Nordisk overtakes LVMH as Europe's most
Novo Nordisk Nears LVMH as Europe's Biggest Firm by Market Value
CHART OF THE DAY: Ozempic maker Novo Nordisk overtakes LVMH to
Novo Nordisk briefly eclipses LVMH as Europe's most valuable company
Ozempic: Metabolizing the market - Quartz
Novo Nordisk briefly overtakes luxury group LVMH as Europe's most
Novo Nordisk briefly overtakes LVMH as Europe's most valuable company